FindTrial
Sign In

Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in infants by affecting serum miR-155

Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in infants by affecting serum miR-155

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026918
Enrollment
Unknown
Registered
2019-10-26
Start date
2019-11-02
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

milk allergy

Interventions

IG and CG groups:oral probiotics

Sponsors

Baohai Liu
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: The infants had milk allergy after they consumed cow milk from Inner Mongolia Mengniu Dairy Co., Ltd. (Hohhot, China); They were younger than 12 months and had the intermittent period of milk allergy of 6 times of milk allergy within one month and allergic symptoms duration of > half an hour at each time.

Exclusion criteria

Exclusion criteria: The following infants were excluded: the infants were allergic to B. bifidum TMC3115 and had serious organ failure, including renal, liver, lung and heart disorders; and they underwent medical therapy for allergy.

Design outcomes

Primary

MeasureTime frame
Rate of milk allergy;—

Countries

China

Contacts

Public ContactJing Wei

Affiliated Hospital of Changchun University of Traditional Chinese Medicine

jingwei20166@126.com+86 13756665383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026